Sudhir Agrawal, D. Phil
2016
In 2016, Sudhir Agrawal, D. Phil earned a total compensation of $1.3M as President of Research at Idera Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,482 |
|---|---|
| Option Awards | $442,289 |
| Salary | $588,100 |
| Other | $32,495 |
| Total | $1,270,366 |
Phil received $588.1K in salary, accounting for 46% of the total pay in 2016.
Phil also received $207.5K in non-equity incentive plan, $442.3K in option awards and $32.5K in other compensation.
Rankings
In 2016, Sudhir Agrawal, D. Phil's compensation ranked 7,097th out of 14,075 executives tracked by ExecPay. In other words, Phil earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,097 out of 14,075 | 50th |
Division Manufacturing | 2,671 out of 5,489 | 51st |
Major group Chemicals And Allied Products | 868 out of 1,895 | 54th |
Industry group Drugs | 668 out of 1,538 | 57th |
Industry Biological Products, Except Diagnostic Substances | 118 out of 279 | 58th |
Source: SEC filing on April 28, 2017.
Phil's colleagues
We found six more compensation records of executives who worked with Sudhir Agrawal, D. Phil at Idera Pharmaceuticals in 2016.
2016
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2016
Mark Casey
Idera Pharmaceuticals
General Counsel
2016
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2016
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2016
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2016
John Kirby
Idera Pharmaceuticals